Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|June 17, 2020
An evaluation of apalutamide for the treatment of prostate cancerMyrto Boukovala, Nicholas Spetsieris, Eleni EfstathiouDrugs & Aging|June 8, 2019
Systemic Treatment of Prostate Cancer in Elderly Patients: Current Role and Safety Considerations of Androgen-Targeting StrategiesMyrto Boukovala, Nicholas Spetsieris, Eleni EfstathiouCancers|December 19, 2020
Neuroendocrine and Aggressive-Variant Prostate CancerNicholas Spetsieris, Myrto Boukovala, Georgios Patsakis, et al.Journal of Community Hospital Internal Medicine Perspectives|October 20, 2022
Pancreatic Cancer with a Skeletal Muscle Metastasis-A Case Presentation and Literature ReviewNicholas Spetsieris, Gayatri Bobba, Priyanka Bhandari, et al.Journal of Community Hospital Internal Medicine Perspectives|January 27, 2025
A Rare Case of Infective Endocarditis Caused by Aerococcus urinaeBenjamin Ossai, Shadan Mehraban, Jonathan London, et al.Proceedings of the National Academy of Sciences of the United States of America|March 27, 2021
Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostateWan-Fu Wu, Li Wang, Nicholas Spetsieris, et al.European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancerNicholas Spetsieris, Myrto Boukovala, Ioannis Alafis, et al.Clinical Genitourinary Cancer|July 18, 2020
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate CancerNicholas Spetsieris, Myrto Boukovala, Justin A Weldon, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2020
A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancerMyrto Boukovala, Nicholas Spetsieris, Justin A Weldon, et al.Nature Biotechnology|June 13, 2022
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progressionShaolong Cao, Jennifer R Wang, Shuangxi Ji, et al.Pageof 1